Breaking News

  • 2 hours ago

  • Pharma Now Editorial Team

Pfizer Advances 25-Valent Pneumococcal Vaccine Into Phase 3 After Positive Infant Trial Data
Breaking News

More News

Immix Biopharma Achieves 95% Complete Response Rate in NEXICART-2 Phase 2 CAR-T Trial

Immix Biopharma Achieves 95% Complete Response Rate in NEXICART-2 Phas...

Pharma Now Editorial Team

Ad
Advertisement
Ad
Advertisement
Ad